BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35802638)

  • 1. A stable XPG protein is required for proper ribosome biogenesis: Insights on the phenotype of combinate Xeroderma Pigmentosum/Cockayne Syndrome patients.
    Taupelet F; Donnio LM; Magnani C; Mari PO; Giglia-Mari G
    PLoS One; 2022; 17(7):e0271246. PubMed ID: 35802638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human XPG nuclease structure, assembly, and activities with insights for neurodegeneration and cancer from pathogenic mutations.
    Tsutakawa SE; Sarker AH; Ng C; Arvai AS; Shin DS; Shih B; Jiang S; Thwin AC; Tsai MS; Willcox A; Her MZ; Trego KS; Raetz AG; Rosenberg D; Bacolla A; Hammel M; Griffith JD; Cooper PK; Tainer JA
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14127-14138. PubMed ID: 32522879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of Transcription Elongation by the XPG-TFIIH Complex Is Implicated in Cockayne Syndrome.
    Narita T; Narita K; Takedachi A; Saijo M; Tanaka K
    Mol Cell Biol; 2015 Sep; 35(18):3178-88. PubMed ID: 26149386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity.
    Lalle P; Nouspikel T; Constantinou A; Thorel F; Clarkson SG
    J Invest Dermatol; 2002 Feb; 118(2):344-51. PubMed ID: 11841555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients.
    Ito S; Kuraoka I; Chymkowitch P; Compe E; Takedachi A; Ishigami C; Coin F; Egly JM; Tanaka K
    Mol Cell; 2007 Apr; 26(2):231-43. PubMed ID: 17466625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function.
    Nouspikel T; Lalle P; Leadon SA; Cooper PK; Clarkson SG
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3116-21. PubMed ID: 9096355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription.
    Schäfer A; Schubert S; Gratchev A; Seebode C; Apel A; Laspe P; Hofmann L; Ohlenbusch A; Mori T; Kobayashi N; Schürer A; Schön MP; Emmert S
    J Invest Dermatol; 2013 Jul; 133(7):1841-9. PubMed ID: 23370536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of XPG protein in human normal and tumor tissues.
    Aracil M; Dauffenbach LM; Diez MM; Richeh R; Moneo V; Leal JF; Fernández LF; Kerfoot CA; Galmarini CM
    Int J Clin Exp Pathol; 2013; 6(2):199-211. PubMed ID: 23330005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the combined Cockayne/xeroderma pigmentosum complex: human XPG protein can function in transcription factor stability.
    Friedberg EC; Wood RD
    Mol Cell; 2007 Apr; 26(2):162-4. PubMed ID: 17466619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.
    Soltys DT; Rocha CR; Lerner LK; de Souza TA; Munford V; Cabral F; Nardo T; Stefanini M; Sarasin A; Cabral-Neto JB; Menck CF
    Hum Mutat; 2013 Mar; 34(3):481-9. PubMed ID: 23255472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncommon nucleotide excision repair phenotypes revealed by targeted high-throughput sequencing.
    Calmels N; Greff G; Obringer C; Kempf N; Gasnier C; Tarabeux J; Miguet M; Baujat G; Bessis D; Bretones P; Cavau A; Digeon B; Doco-Fenzy M; Doray B; Feillet F; Gardeazabal J; Gener B; Julia S; Llano-Rivas I; Mazur A; Michot C; Renaldo-Robin F; Rossi M; Sabouraud P; Keren B; Depienne C; Muller J; Mandel JL; Laugel V
    Orphanet J Rare Dis; 2016 Mar; 11():26. PubMed ID: 27004399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xeroderma pigmentosum and molecular cloning of DNA repair genes.
    Boulikas T
    Anticancer Res; 1996; 16(2):693-708. PubMed ID: 8687116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hot topics in DNA repair: the molecular basis for different disease states caused by mutations in TFIIH and XPG.
    Schärer OD
    DNA Repair (Amst); 2008 Feb; 7(2):339-44. PubMed ID: 18077223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective transcription-coupled repair of oxidative base damage in Cockayne syndrome patients from XP group G.
    Cooper PK; Nouspikel T; Clarkson SG; Leadon SA
    Science; 1997 Feb; 275(5302):990-3. PubMed ID: 9020084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPG: its products and biological roles.
    Schärer OD
    Adv Exp Med Biol; 2008; 637():83-92. PubMed ID: 19181113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
    Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
    Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPG: a multitasking genome caretaker.
    Muniesa-Vargas A; Theil AF; Ribeiro-Silva C; Vermeulen W; Lans H
    Cell Mol Life Sci; 2022 Mar; 79(3):166. PubMed ID: 35230528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription-coupled repair of 8-oxoguanine: requirement for XPG, TFIIH, and CSB and implications for Cockayne syndrome.
    Le Page F; Kwoh EE; Avrutskaya A; Gentil A; Leadon SA; Sarasin A; Cooper PK
    Cell; 2000 Apr; 101(2):159-71. PubMed ID: 10786832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia.
    Kashiyama K; Nakazawa Y; Pilz DT; Guo C; Shimada M; Sasaki K; Fawcett H; Wing JF; Lewin SO; Carr L; Li TS; Yoshiura K; Utani A; Hirano A; Yamashita S; Greenblatt D; Nardo T; Stefanini M; McGibbon D; Sarkany R; Fassihi H; Takahashi Y; Nagayama Y; Mitsutake N; Lehmann AR; Ogi T
    Am J Hum Genet; 2013 May; 92(5):807-19. PubMed ID: 23623389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
    Emmert S; Slor H; Busch DB; Batko S; Albert RB; Coleman D; Khan SG; Abu-Libdeh B; DiGiovanna JJ; Cunningham BB; Lee MM; Crollick J; Inui H; Ueda T; Hedayati M; Grossman L; Shahlavi T; Cleaver JE; Kraemer KH
    J Invest Dermatol; 2002 Jun; 118(6):972-82. PubMed ID: 12060391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.